Emerging circulating biomarkers for the diagnosis and assessment of treatment responses in patients with hepatic fat accumulation, nash and liver fibrosis

Marta Iruarrizaga-Lejarreta; Fernando Bril; Mazen Noureddin; Pablo Ortiz; Shelly C. Lu; José M. Mato; Cristina Alonso

doi:10.1007/978-3-030-11748-1_16

Emerging circulating biomarkers for the diagnosis and assessment of treatment responses in patients with hepatic fat accumulation, nash and liver fibrosis

Marta Iruarrizaga-Lejarreta, Fernando Bril, Mazen Noureddin, Pablo Ortiz, Shelly C. Lu, José M. Mato, Cristina Alonso

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Original language	English (US)
Title of host publication	Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease
Subtitle of host publication	A Focus on Early Phase Clinical Drug Development
Publisher	Springer International Publishing
Pages	423-448
Number of pages	26
ISBN (Electronic)	9783030117481
ISBN (Print)	9783030117474
DOIs	https://doi.org/10.1007/978-3-030-11748-1_16
State	Published - Apr 2 2019

ASJC Scopus subject areas

Medicine(all)
Pharmacology, Toxicology and Pharmaceutics(all)

Access to Document

10.1007/978-3-030-11748-1_16

Cite this

Iruarrizaga-Lejarreta, M., Bril, F., Noureddin, M., Ortiz, P., Lu, S. C., Mato, J. M., & Alonso, C. (2019). Emerging circulating biomarkers for the diagnosis and assessment of treatment responses in patients with hepatic fat accumulation, nash and liver fibrosis. In Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease: A Focus on Early Phase Clinical Drug Development (pp. 423-448). Springer International Publishing. https://doi.org/10.1007/978-3-030-11748-1_16

Emerging circulating biomarkers for the diagnosis and assessment of treatment responses in patients with hepatic fat accumulation, nash and liver fibrosis. / Iruarrizaga-Lejarreta, Marta; Bril, Fernando; Noureddin, Mazen et al.
Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease: A Focus on Early Phase Clinical Drug Development. Springer International Publishing, 2019. p. 423-448.

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Iruarrizaga-Lejarreta, M, Bril, F, Noureddin, M, Ortiz, P, Lu, SC, Mato, JM & Alonso, C 2019, Emerging circulating biomarkers for the diagnosis and assessment of treatment responses in patients with hepatic fat accumulation, nash and liver fibrosis. in Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease: A Focus on Early Phase Clinical Drug Development. Springer International Publishing, pp. 423-448. https://doi.org/10.1007/978-3-030-11748-1_16

Iruarrizaga-Lejarreta M, Bril F, Noureddin M, Ortiz P, Lu SC, Mato JM et al. Emerging circulating biomarkers for the diagnosis and assessment of treatment responses in patients with hepatic fat accumulation, nash and liver fibrosis. In Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease: A Focus on Early Phase Clinical Drug Development. Springer International Publishing. 2019. p. 423-448 doi: 10.1007/978-3-030-11748-1_16

Iruarrizaga-Lejarreta, Marta ; Bril, Fernando ; Noureddin, Mazen et al. / Emerging circulating biomarkers for the diagnosis and assessment of treatment responses in patients with hepatic fat accumulation, nash and liver fibrosis. Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease: A Focus on Early Phase Clinical Drug Development. Springer International Publishing, 2019. pp. 423-448

@inbook{c4cdd1b3d2d54ff4ae4aaa1228db4472,

title = "Emerging circulating biomarkers for the diagnosis and assessment of treatment responses in patients with hepatic fat accumulation, nash and liver fibrosis",

author = "Marta Iruarrizaga-Lejarreta and Fernando Bril and Mazen Noureddin and Pablo Ortiz and Lu, {Shelly C.} and Mato, {Jos{\'e} M.} and Cristina Alonso",

year = "2019",

month = apr,

day = "2",

doi = "10.1007/978-3-030-11748-1_16",

language = "English (US)",

isbn = "9783030117474",

pages = "423--448",

booktitle = "Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Emerging circulating biomarkers for the diagnosis and assessment of treatment responses in patients with hepatic fat accumulation, nash and liver fibrosis

AU - Iruarrizaga-Lejarreta, Marta

AU - Bril, Fernando

AU - Noureddin, Mazen

AU - Ortiz, Pablo

AU - Lu, Shelly C.

AU - Mato, José M.

AU - Alonso, Cristina

PY - 2019/4/2

Y1 - 2019/4/2

UR - http://www.scopus.com/inward/record.url?scp=85068553760&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068553760&partnerID=8YFLogxK

U2 - 10.1007/978-3-030-11748-1_16

DO - 10.1007/978-3-030-11748-1_16

M3 - Chapter

AN - SCOPUS:85068553760

SN - 9783030117474

SP - 423

EP - 448

BT - Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease

PB - Springer International Publishing

ER -

Emerging circulating biomarkers for the diagnosis and assessment of treatment responses in patients with hepatic fat accumulation, nash and liver fibrosis

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this